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Abstract
Background: Recently the use of indoor residual spraying of insecticide (IRS) has greatly increased in Africa; however,
limited data exist on the quantitative impacts of IRS on health outcomes in highly malaria endemic areas.
Methodology/Principal Findings: Routine data were collected on more than 90,000 patient visits at a single health facility
over a 56 month period covering five rounds of IRS using three different insecticides. Temporal associations between the
timing of IRS and the probability of a patient referred for microscopy having laboratory confirmed malaria were estimated
controlling for seasonality and age. Considering patients less than five years of age there was a modest decrease in the odds
of malaria following the 1st round of IRS using DDT (OR = 0.76, p,0.001) and the 2nd round using alpha-cypermethrin
(OR= 0.83, p = 0.002). Following rounds 3–5 using bendiocarb there was a much greater decrease in the odds of malaria
(ORs 0.34, 0.16, 0.17 respectively, p,0.001 for all comparisons). Overall, the impact of IRS was less pronounced among
patients 5 years or older.
Conclusions/Significance: IRS was associated with a reduction in malaria morbidity in an area of high transmission intensity
in Uganda and the benefits appeared to be greatest after switching to a carbamate class of insecticide.
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Introduction
Malaria is a leading cause of morbidity and mortality in Uganda
with an estimated 8–13 million cases per year accounting for 30–
50% of outpatient visits, 35% of hospital admissions and 9–14% of
hospital deaths, with nearly half of those in children less than 5
years of age [1]. The primary interventions for malaria control in
Uganda have been the distribution of insecticide treated bed nets
(ITNs) and prompt treatment with artemisinin-based combination
therapy (ACT). Historically, indoor residual spraying of insecticide
(IRS) has played an important role in the prevention of malaria
and more recently, several countries in sub-Saharan Africa have
added IRS as part of their malaria control plan in line with the
Global Malaria Action Plan launched by the WHO-Roll Back
Malaria Partnership [2]. In 2006, Uganda began using IRS in
selected districts, initially focusing on epidemic prone regions in
the Southwest, but subsequently shifting to highly endemic areas
in the North in accordance with the WHO position statement on
IRS in hyperendemic areas [3].
IRS was a critical component of the WHO’s Global Malaria
Eradication Program from 1955–1969 and the main intervention
contributing to the elimination or dramatic reduction of malaria in
parts of Europe, Asia, and Latin America [4]. Additionally, several
historical reviews have documented programmatic benefits of
successful IRS programs in Africa, primarily in the southern part
of the continent [5,6,7,8,9,10]. These reviews reported clear and
substantial reductions in various malaria related outcomes and
measures of vector density, and in some instances local elimination
was achieved. However, most of these studies lacked an
appropriate control group needed to accurately quantify the
impact of IRS. A recent Cochrane Review of IRS for preventing
malaria using strict criteria necessary to quantify impact identified
only 4 studies from Africa, of which 3 were from areas of stable
transmission and 2 were randomized controlled trials [4]. Thus,
there is an urgent need for additional studies aimed at estimating
the quantitative impact of IRS on relevant health outcomes in
different epidemiological settings. In addition, resistance to
insecticides including dichloro-diphenyl-trichloroethane (DDT)
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and several pyrethroids have become of increasing concern in
Uganda and other parts of Africa [11,12,13,14,15]. The WHO
recommends a number of insecticides for IRS, however, there is
limited evidence to guide which class of insecticide should be used
in different settings.
In this study, data from a health facility-based malaria
surveillance program were used to estimate the impact of IRS
on malaria morbidity in the Apac District of Uganda, an area of
very high transmission intensity. The probability of having malaria
parasitemia among patients referred for microscopy from the
outpatient department of a single government health center was
used as the primary indicator of morbidity. These data were
collected over a 4K year period, covering 5 rounds of IRS using 3
different classes of insecticide.
Methods
Study site and participants
The Ugandan Malaria Surveillance Program (UMSP) in
collaboration with the National Malaria Control Program
(NMCP) runs a sentinel site health facility-based malaria
surveillance system at six level IV government health centers
around the country. As part of this program individual-level data
on all patients presenting to the outpatient department of the
sentinel site facilities are collected using an electronic data
collection system. Data collected includes patient demographic
information, basic clinical information, laboratory results, diagno-
ses, and treatments prescribed. A strong emphasis is placed on
referral of patients with suspected malaria for laboratory testing
using microscopy (thick blood smear) and the training of health
care workers and laboratory technicians [16].
This study included one sentinel site health facility, Aduku
Health Center, located in the Apac district of Northern Uganda.
Malaria transmission in this area is perennial, with 2 peaks
following the rainy seasons, and had an entomological inoculation
rate estimated to be 1586 infectious bites per person per year in
2001 [17]. Of note, the activities of this sentinel site malaria
surveillance program were established independent of the IRS
activities described below.
Ethics statement
The data included in this report were considered routine public
health surveillance and not classified as research requiring approval
from an institutional review board according to CDC policy
(http://www.cdc.gov/od/science/integrity/docs/cdc-policy-disti
nguishing-public-health-research-nonresearch.pdf). Data did not
include any patient identifiers and were analyzed anonymously.
Description of IRS activities in the Apac District
Over the 4 K year study period, 5 rounds of IRS were
completed (Table 1). Round 1 occurred from March-May 2008
using DDT, round 2 occurred from March-April 2010 using the
pyrethroid alpha-cypermethrin, and rounds 3–5 occurred at
approximately 5 months intervals from August 2010 through
June 2011 using the carbamate bendiocarb. Coverage of
households sprayed and population protected was over 90% in
round 1 and over 99% in rounds 2–5. The almost 2 year delay
between the 1st and 2nd rounds of IRS was due to a court
injunction by local organic farmers against the use of DDT. The
switch from a pyrethroid to a carbamate class of insecticide
between the 2nd and 3rd rounds was based on evidence
demonstrating significant resistance to both DDT and pyrethroids
but no resistance to carbamates among Anopheles gambiae in the area
(submitted for publication).
Statistical analysis
This study utilized data collected as part of the sentinel site
malaria surveillance system from March 2007 through October
2011. Suspected malaria was defined as all patients referred for
malaria laboratory testing plus all patients not referred to the
laboratory but given a clinical diagnosis of malaria. The primary
exposure variable of interest was calendar time in relationship to
IRS. A categorical time variable was created that included the 6
month period following the 1st round of IRS with DDT, each 4
month period following rounds 2–5 of IRS with a-cypermethrin
and then bendiocarb. The longer period following DDT was done
to reflect its longer duration of action and the fact that the period
between rounds 2–5 was approximately 4 months. The baseline
time period (for which each post-IRS time period was compared
with) included all observations between March 2007 through
October 2011 excluding the time periods of interest following each
round of IRS described above. The primary outcome of interest
was the proportion of patients with blood slide results (denomi-
nator) that were positive for asexual parasites (numerator),
commonly referred to as the slide positivity rate (SPR). Associa-
tions between time periods of interest and the probability of having
a positive blood slide result if a blood slide result was done were
expressed as an odds ratio (OR) using a logistic regression model
controlling for age, monthly seasonality and autocorrelation by
including a quadratic term for the day of observation. Data were
stratified for patients under 5 years of age and those 5 years of age
or older. Analyses were performed separately for all patients
regardless of residence and then restricted to only those who
reported residing within the Aduku sub-county where the sentinel
site health center was located. A p-value ,0.05 was considered
statistically significant.
Results
Characteristics of patients
Characteristics of individual patient level data collected as part
of the surveillance system are included in Table 2. In total, 90,231
patient encounters were included over the 56 month study period.
Overall 51% of patients had suspected malaria. Interestingly, the
proportion of patients with suspected malaria increased signifi-
cantly between the first and second half of the observation period
(44% vs. 57%, p,0.001). Among patients with suspected malaria
less than 1% had no age recorded and 16% had no blood smear
results. The proportion of patients with suspected malaria who did
not undergo microscopy decreased significantly from 37% during
the first half of the observation period to less than 3% during the
second half of the observation period (p,0.001). A total of 38,336
patient encounters among patients with suspected malaria,
reported age, and microscopy results were included in the analyses
of temporal changes in morbidity in relationship to IRS. Among
patients with complete data, less than 1% reported residing outside
the Apac district where IRS was conducted and 57% reported
residing in the Aduku sub-county where the sentinel site health
facility was located.
Associations between the timing of IRS and temporal
changes in malaria morbidity
Temporal trends in the monthly SPR stratified by age groups
are presented in Figure 1. Considering the reference time period,
the SPR was 71% for patients under 5 years of age and 36% for
patient 5 years of age or older. During the 6 months following the
1st round of IRS with DDT there was a significant decrease in the
odds of having malaria among patients less than 5 years of age
(OR=0.76, 95% CI 0.67–0.86, p,0.001) and those 5 years of age
IRS and Malaria Morbidity in Uganda
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or older (OR=0.70, 95% CI 0.61–0.79, p,0.001). During the 4
months following the 2nd round of IRS with alpha-cypermethrin
there was a significant decrease in the odds of having malaria
among patients less than 5 years of age (OR=0.83, 95% CI 0.73–
0.93. p = 0.002), but not among those 5 years of age or older
(OR=1.09, 95% CI 0.99–1.22. p= 0.10) (Table 3). During the 4
months following the 3rd round of IRS with bendiocarb there was
a significant decrease in the odds of having malaria that was more
pronounced among patients less than 5 years of age (OR=0.34,
95% CI 0.30–0.40, p,0.001) compared to those 5 years of age or
older (OR=0.76, 95% CI 0.68–0.84, p,0.001)(p,0.001 for
interaction when comparing effects between two age groups). The
greatest decrease in the odds of having malaria occurred during
the 4 months following the 4th and 5th rounds of IRS using
bendiocarb and was more pronounced among patients less than 5
years of age (ORs 0.16, 95% CI 0.14–0.19, p,0.001; and 0.17,
95% CI 0.15–0.20, p,0.001) compared to those 5 years of age or
older (ORs 0.44, 95% CI 0.38–0.50, p,0.001, and 0.58, 95% CI
0.52–0.65, p,0.001)(p,0.001 for interaction when comparing
effects between two age groups). There was a sharp decline in the
SPR following the 3rd round of IRS (1st round with bendiocarb),
sustained initially after the 4th round of IRS, then increasing prior
to the 5th round followed by another sharp decline (Figure 1).
Results were similar when restricting the analyses to only patients
who reported residing in the Aduku sub-county (Table 3).
Over the course of the IRS program there was a demographic
shift to an older age range among patients with suspected malaria
referred for microscopy. The proportion of patients referred for
microscopy who were under 5 years of age was 32% and remained
relatively unchanged before the first round of IRS through the
period 4 months after the 2nd round of IRS. However, in the 4
months following the 3rd through 5th rounds of IRS, the
proportion of patients referred for microscopy who were under 5
years of age decreased to 19% (p,0.001).
Discussion
The Uganda National Malaria Control Program (NMCP)
strategic plan now recognizes IRS as one of the major malaria
prevention and control interventions in the country. The NMCP
began large-scale IRS campaigns in selected districts with support
from the U.S. President’s Malaria Initiative in 2006 after an
absence of such activities since the 1960s. Since 2008, the IRS
program has focused on ten high transmission districts in Northern
Uganda, targeting nearly 3 million people living in 850,000
households. Due to emerging vector resistance patterns the choice
of insecticide class has evolved from DDT to pyrethroids to
carbamates. Vector resistance monitoring using standard WHO
Table 1. Details of indoor residual insecticide spraying (IRS).
Formulation of insecticide Dates of spraying
Percentage of households
sprayed
Percentage of the population
protected
DDT March 2008–May 2008 92.4% 91.0%
alpha-cypermethrin March 9th 2010–March 31st 2010 99.9% 99.9%
bendiocarb August 23rd 2010–September 21st 2010 99.6% 99.6%
bendiocarb January 5th 2011–January 29th 2011 99.4% 99.3%
bendiocarb May 23rd 2011–June 20th 2011 96.8% 96.8%
doi:10.1371/journal.pone.0042857.t001
Table 2. Characteristics of the study population.
Entire observation period
(March 2007–October 2011)
First half of observation
period (March 2007–June
2009)
Second half of observation
period (July 2009–October
2011)
Total number of patients encounters 90,231 42,619 47,612
Suspected malaria (% total) 46,090 (51%) 18,944 (44%) 27,146 (57%)
Missing data if malaria suspected
No age 120 (0.3%) 42 (0.2%) 78 (0.3%)
No blood smear result 7,734 (16%) 6,930 (37%) 704 (2.6%)
Complete data if malaria suspected 38,336 (83%) 11,972 (63%) 26,364 (97%)
Geographic strata if malaria suspected and complete data
Residence missing 5,252 (14%) 4,016 (34%) 1,236 (4.7%)
Resident outside Apac district 95 (0.3%) 45 (0.4%) 50 (0.2%)
Resident of Apac district outside Aduku sub-county 11,236 (29%) 2,479 (21%) 8,757 (33%)
Resident of Aduku sub-county 21,753 (57%) 5,432 (45%) 16,321 (62%)
Age strata if malaria suspected and complete data
,5 years of age 16,382 (43%) 6,452 (54%) 9,930 (38%)
$5 years of age 21,954 (57%) 5,520 (46%) 16,434 (62%)
doi:10.1371/journal.pone.0042857.t002
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testing methods conducted from August-October 2009 in this area
revealed Anopheles gambiae was highly resistant to DDT, partially
resistant to pyrethoids (etofenprox and lamdacyhalothrin), and full
susceptibility to both carbamates and organophosphates (submit-
ted for publication). Here we describe the first published report of
the impact of IRS on health outcomes in one of these high
transmission districts of Uganda (Apac) using a health-facility
based malaria surveillance system. In the 6 months following the
first round of IRS with DDT there was evidence of a modest
decrease in measures of malaria morbidity. Following a 22 month
delay between the 1st and 2nd rounds of IRS, there was again
evidence of modest decrease in malaria morbidity in the 4 months
following the 2nd round of IRS with alpha-cypermethrin, but only
among patients less than 5 years of age. Following the 3rd through
5th rounds of IRS with bendiocarb, there was a more dramatic
decrease in malaria morbidity. These decreases were greatest in
the younger age group and there was a shift towards an older
patient population presenting with suspected malaria.
The use of IRS in the African region has greatly increased in
recent years with 36 countries recommending IRS and an
estimated 78 million people protected in 2010, up from 10 million
in 2005 [18]. Despite the dramatic recent increase in the use of
IRS and clear evidence from historical reviews in Africa that IRS
reduces transmission and leads to substantial epidemiological
benefit, there are very limited data from controlled trials
quantifying the impact of IRS on health outcomes from this
region [4]. In a randomized controlled trial (RCT) of IRS with the
pyrethroid deltamethrin versus ITNs in an area of unstable
transmission in South Africa, IRS was associated with a 34%
protective efficacy in the incidence of infection, but this difference
was not statistically significant [19]. In a RCT from a highly
endemic area of Tanzania, the use of IRS with the pyrethroid
lambdacyhalothrin compared to a control group with no
intervention was associated with a 54% reduction (95% CI 49–
58%) in the incidence of reinfection and a 14% reduction (95% CI
5–23%) in the incidence of malaria among children 1–5 years but
no difference in parasite prevalence or the incidence of malaria
among children older than 5 years [20]. In a controlled before-
and-after study from the early 1970’s in an area of stable malaria
transmission in Nigeria, the use of IRS with the carbamate
propoxur was associated with a 26% protective efficacy (95% CI
20–32%) against malaria prevalence during the wet season but no
protection during the dry season [21]. In an interrupted time series
study from an area of stable transmission in Mozambique,
sustained use of IRS with the carbamate bendiocarb over a 5
year period was associated with a 74% protective efficacy (95% CI
72–76%) against malaria prevalence [22]. Finally, using health
facility-based data from an area of moderate transmission intensity
in Southwest Uganda, a single round of IRS with the pyrethroid
lambdacyhalothrin was associated with a decrease in the SPR
from 47% to 14% among patient less than 5 years of age during
the 4 month period following the intervention but this effect waned
over the subsequent 12 months [23]. The results presented in this
study provide further evidence of the quantitative impact of IRS
on measures of malaria morbidity in an area of high transmission
intensity and is novel in its assessment of multiple rounds of IRS
using different classes of insecticide. One of the interesting findings
in this study was the more profound decrease in malaria morbidity
following IRS with bendiocarb in patient under 5 years of age
compared to those 5 years of age or older. This difference may be
due to lower levels of antimalarial immunity in younger patients,
making them more dependent on interventions for the control of
malaria.
The choice of class of insecticide for IRS has become a critical
issue with the emergence of insecticide resistance. In 2009,
pyrethroids were estimated to account for 77% of spray area
covered, DDT accounted for 20% of sprayed areas, and
carbamates and organophosphates represented a very small
proportion of global usage for vector control [18]. However,
recent data suggest that resistance to DDT and various pyrethroids
among the main Anopheles vectors may be commonplace in many
parts of Africa, including Uganda [18]. The main vector species in
Uganda are An. gambiae and An. funestus [17] and resistance to DDT
and pyrethoids have been described recently to both of these
species in the central and eastern part of the country [13,14,15]. In
the Apac district, the site of this study, data collected from 2004–
Figure 1. Monthly trends in malaria slide positivity stratified by age groups among patients with suspected malaria referred for
laboratory testing at the Aduku Health Center in Apac, Uganda. Vertical bars represent the duration of each round of IRS.
doi:10.1371/journal.pone.0042857.g001
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06 demonstrated significant resistance by An. gambiae to DDT (24-
hr mortality 63–76%) and permethrin (24-hr mortality 80–81%)
and to a lesser extent by An. funestus to DDT (24-hr mortality 81–
100%) and permethrin (24-hr mortality 92–99%) [15]. Similar
patterns of insecticide resistance have been reported in other
African countries [24] and a recent report from Benin document-
ed dramatic decreases in entomological measures of transmission
following large-scale IRS with bendiocarb in areas with high
resistance of An. gambiae to pyrethroids [25]. However, this is the
first report documenting substantial decreases in measures of
malaria morbidity following repeated rounds of IRS with
bendiocarb after more modest decreases following IRS with
DDT and then pyrethroids.
There were several limitations to this study. An interrupted time
series study design was used therefore caution should be taken
when making causal inferences about the quantitative impact of
the intervention given the lack of a contemporaneous control
group. Temporal changes in measures of malaria morbidity could
have been influenced by several potential confounding factors
which were not controlled for such as environmental factors
associated with malaria transmission intensity and changes in the
coverage of other malaria control interventions. For example,
changes in the use of ITNs were not controlled for in this study.
Data from malaria indicator surveys done in the mid-Northern
region of the country involving 9 districts including Apac reported
64% of households owned at least one ITN in 2009 and this
increased to 82% in late 2010 (Uganda Ministry of Health,
unpublished data). Therefore decreases in measures of malaria
morbidity seen in this study could have been partially due to
increasing ITN coverage and not just a result of IRS. In a recent
non-randomized prospective cohort study from Western Kenya,
IRS with ITNs was associated with a 62% protective efficacy
against the incidence of malaria parasitemia compared to ITNs
alone [26]. This study is also unable to separate out the
independent effects of the various rounds of IRS using different
classes of insecticide. For example the dramatic decrease in
malaria morbidity seen after rounds 3–5 using bendiocarb may
have been different if this was not preceded by the previous 2
rounds using DDT and alpha-cypermethrin, respectively. Indeed,
it has been suggested that in very high transmission settings several
years of IRS may be needed to have an appreciable health impact
[27]. Another limitation of this study is the use of the SPR as the
primary outcome measure of malaria morbidity. The SPR has a
non-linear relationship with malaria incidence in a target
population and may be influenced by other factors such as the
incidence of non-malarial fevers [28]. In addition, the SPR is
dependent on which patients are determined to have suspected
malaria and the proportion of patients with suspected malaria who
undergo diagnostic testing. Both of these factors changed over the
course of the observation period and could have led to bias in
estimates of SPR, although this potential source of bias could have
changed estimates of SPR in either direction. Despite these
limitations, the use of health facility-based data remains an
efficient and practical means of monitoring temporal changes in
malaria morbidity in the setting of routine malaria surveillance.
Despite these limitations, the consistent and profound decrease in
SPR seen following the last three rounds of IRS in this study
provides evidence for the overall effectiveness of a sustained IRS
program in a high transmission setting on reducing the burden of
malaria, although caution must be taken about making causal
inferences about the temporal associations between IRS and
malaria morbidity given the study design.
In summary, IRS was associated with a reduction in malaria
morbidity in an area of high transmission intensity in Uganda and
the benefits appeared to be greatest after switching to a carbamate
class of insecticide. Further studies are needed to better quantify
the impact of IRS in different epidemiological settings and identify
the optimal class of insecticides and spraying schedules. In
addition, future studies should also attempt to better delineate
the incremental benefits of IRS in the setting of other malaria
control interventions.
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